Established in May 2016, The AMR Centre is a key part of the UK’s response to the global threat from Antimicrobial Resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept.
Breaking News
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development agreement with Massachusetts-based clinical stage biopharmaceutical company Microbiotix, Inc. to progress a novel treatment to…
World Antibiotic Awareness Week Video
This week is World Antibiotic Awareness Week.
Latest News
The AMR Centre signs agreement to co-develop treatment for gonorrhoea
The AMR Centre (AMRC) has today announced a multi-year co-development agreement with…
More People in the United States Dying from Antibiotic-Resistant Infections than Previously Estimated
Significant progress since 2013 could be lost without more action
AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes
The AMR Centre has nominated a preclinical candidate in its program that tackles drug…
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma…
Partnering for 2019
The AMR Centre is searching for new collaborative opportunities throughout 2019.
AMR Centre marks UN International Day of Women and Girls in Science
Today marks the official UN International Day of Women and Girls in Science.
AMR Centre hails government action plan as ‘critical step’ in tackling antibiotic crisis
Today’s announcement by the UK Government on the launch of a trial to evaluate a new way…
International Trade Minister visits AMR Centre
The AMR Centre was delighted to welcome Baroness Rona Fairhead to Alderley Park, where…